Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2395 (LINC02395)
- Target
- LINC02395
- Molecular classification
- Long non-coding RNA, Long intergenic non-protein coding RNA
01
Overview
Long intergenic non-protein coding RNA 2395 (LINC02395) is a human long intergenic non-coding RNA (lincRNA), defined as a non-coding RNA longer than 200 nucleotides that is transcribed from intergenic regions of the genome and does not overlap any protein-coding genes[1][3][7]. LincRNAs, including LINC02395, are part of the broader lncRNA class and are thought to play important regulatory roles, such as chromatin and genome remodeling, transcriptional modulation, RNA stabilization, and scaffolding of regulatory protein complexes[1][3]. While some lincRNAs have established roles in development and disease, there is currently no disease association or drug targeting specifically described for LINC02395. This molecule chiefly represents a structural and regulatory RNA without protein-coding potential, and remains a subject of functional genomics research rather than a therapeutic target[1][3][7].
- Other names
- LINC02395
02
Mechanism of action
Not applicable (no drugs known to target this molecule)
03
Biological functions
Chromatin remodelingRegulation of genome architectureRNA stabilizationTranscription regulationPotential enhancer-associated activityScaffolding and modulation of protein activityFine-tuning expression of neighboring genes
04
Disease associations
Other (while many lincRNAs/lncRNAs have been linked to diseases including cancer, there is no direct evidence currently linking LINC02395 itself to human disease)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2395 (LINC02395).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2395 (LINC02395).